The association of STAT3 hyperactivation with poor prognosis, resistance to therapies, and immune escape makes it a tempting target in HNSCC, particularly in HPV-negative HNSCC, where treatment targeting this pathway may be effective [34]. Here, STAT3 is linked to head and neck squamous cell carcinoma.